Studies on the Efficacy and Safety of Deferasirox for Iron Chelation in Patients with MDS: EPIC and US03

Safety and Efficacy of Combination Therapies with Azacitidine in Elderly Patients with AML or MDS

Phase II Study of Maintenance Treatment with 5-Azacitidine for Patients with MDS or Post-MDS AML

Patterns of Care Survey for Myelodysplastic Syndromes (MDS)

Studies on the Efficacy and Safety of Deferasirox for Iron Chelation in Patients with MDS: EPIC and US03

Lenalidomide Activity in AML with Trisomy 13

Patterns of Care Survey for Acute Myeloid Leukemia (AML)

Five-Day Decitabine Therapy for Elderly Patients with Acute Myeloid Leukemia (AML)

CIBMTR Analysis of HCT in Older Patients with AML or MDS

New Prognostic Markers in Acute Myeloid Leukemia (AML)

Phase II Study of Clofarabine for Older Patients with Treatment-Naïve AML

A Prognostic Model for MDS that Accounts for Events Not Considered by the International Prognostic Scoring System (IPSS)

Three Alternate Dosing Schedules of Azacitidine for MDS

EORTC-06011: Low-Dose Decitabine versus Best Supportive Care for Elderly Patients with Intermediate- or High-Risk MDS

Myelodysplastic Syndromes